Chronic Hepatitis B Treatment Eligibility and Actual Treatment Rates in Patients in Community Gastroenterology and Primary Care Settings
Chronic Hepatitis B Treatment Eligibility and Actual Treatment Rates in Patients in Community Gastroenterology and Primary Care Settings
复制标题
DOI：
10.1097/mcg.0000000000000132
复制
发表时间：
2015-02-01
影响因子：
2.9
通讯作者：
Nguyen, Mindie H.
中科院分区：
文献类型：
--
作者：
Nguyen, Vincent G.;Wan, Kenton;Nguyen, Mindie H.
目标：本研究旨在比较胃肠病[胃肠(GI)]专家评估的慢性乙型肝炎(CHB)患者和仅由他们的初级保健医生(PCP)跟踪治疗的患者的合格率和治疗率。背景：已经制定了指导CHB患者护理的指南，但这些指南的应用数据，特别是在初级保健环境中的应用数据迄今有限。研究：连续的CHB患者是从旧金山湾区的几个社区诊所回顾登记的：2个胃肠道转诊诊所，3个初级保健诊所，和一个多专科医疗中心。如果患者在发病后6个月内因慢性乙肝去看胃肠科医生，则被归类为第1组，如果他们只看PCP，则被归类为第2组。根据AASLD 2009和US Panel 2008指南，使用在陈述后6个月内获得的临床和实验室数据来确定符合条件。结果：根据US Panel 2008和US Panel 2008，第2组患者的合格率较低(32%比51%，P
Goals: This study aims to compare the eligibility and treatment rates of patients evaluated by gastroenterology [gastrointestinal (GI)] specialists for chronic hepatitis B (CHB) and patients followed by their primary care physicians (PCPs) only.Background: Guidelines have been devised to direct the care of patients with CHB but data on the application of these guidelines, especially in primary care settings, has been limited to date.Study: Consecutive CHB patients were enrolled retrospectively from several community clinics in the San Francisco Bay Area: 2 GI referral clinics, 3 primary care clinics, and a multispecialty medical center. Patients were classified as group 1 if they saw a gastroenterologist for CHB within 6 months of presentation or as group 2 if they only saw PCPs. Eligibility according to AASLD 2009 and US Panel 2008 guidelines was determined using clinical and laboratory data available within 6 months of presentation.Results: Patients in group 2 had lower eligibility rates according to both US Panel 2008 (32% vs. 51%, P